JPMorgan analyst Anupam Rama added Nuvalent (NUVL), Olema Oncology (OLMA) and Oric Pharmaceuticals (ORIC) to the firm’s “Catalyst Watch List” in the positive category ahead of the medical conference updates in October. The analyst keeps Overweight ratings on the three stocks.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NUVL: